Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date December 01, 2008 · Filed December 01, 2008
Section 16 reporting ended · disclosed 2008-12-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 19,841 |
Reported balance
After 2008-12-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2008-12-01 · Grant · Acquired 2,567 · Balance 19,841 F1: Shares acquired pursuant to the Directors Compensation Plan. F2: Not Applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired pursuant to the Directors Compensation Plan.
F2: Not Applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2008 Filed Dec 1, 2008 22:46 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 2,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000097 · led687.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,841 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| May 30, 2008 Filed May 30, 2008 21:30 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000067 · led674.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,274 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| December 01, 2007 Filed Dec 4, 2007 21:50 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000084 · led635.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,594 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| June 01, 2007 Filed Jun 4, 2007 20:46 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,018 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000056 · led622.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,530 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 20:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000132 · led587.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,512 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| June 01, 2006 Filed Jun 5, 2006 19:45 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,748 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000088 · led555.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,998 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| May 20, 2006 Filed May 23, 2006 19:57 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000062 · led546.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,250 F1 · price: Not Applicable. Read SEC document |
| January 01, 2006 Filed Jan 4, 2006 19:37 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,199.04 | $20.85 | $24,999.98 |
DisclosureSEC source: 0000310158-06-000010 · led510.xml · derivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,161.8 Underlying: Common Shares · 1,199.04 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Stock Equivalency Program, as of November 30, 2005. Read SEC document |
| April 27, 2005 Filed Apr 29, 2005 19:03 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000032 · led469.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 F1 · price: Not Applicable. Read SEC document |
| January 01, 2005 Filed Jan 4, 2005 19:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,197.32 | $20.88 Strike: $0.00 | $25,000.04 |
DisclosureSEC source: 0001223203-05-000015 · led449.xml · derivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,929.98 Underlying: Common Shares · 1,197.32 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Stock Equivalency Program, as of November 30, 2004. Read SEC document |
| April 28, 2004 Filed Apr 29, 2004 21:24 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-04-000069 · led391.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 F1 · price: Not Applicable. Read SEC document |
| January 01, 2004 Filed Jan 5, 2004 21:15 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,437.61 | $17.39 Strike: $0.00 | $25,000.04 |
DisclosureSEC source: 0000310158-04-000008 · led320.xml · derivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,711.46 Underlying: Common Shares · 1,437.61 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes 0.98 shares acquired pursuant to a dividend reinvestment feature of the Directors Stock Equivalency Program, through November 26, 2003. Read SEC document |
| November 01, 2003 Filed Nov 4, 2003 16:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 272.87 | $15.27 Strike: $0.00 | $4,166.72 |
DisclosureSEC source: 0000310158-03-000101 · led252.xml · derivative · entry 2 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272.87 Underlying: Common Shares · 272.87 shares Expires not disclosed F2 · derivative.exercise_price: 1 for 1 F3 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Plan. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. Read SEC document |
| November 01, 2003 Filed Nov 4, 2003 16:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-03-000101 · led252.xml · nonDerivative · entry 1 LEDER PHILIP · CIK 0001083219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 F1 · price: Not Applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.